Here is a risk you should consider in any such strategy, IMO: short borrow costs can spike up to astronomical levels, e.g. 400% per year for KBIO during its Martin Shkreli drama last November/December. (My guess is that much of that was being collected by Shkreli himself through one of those "revenue sharing" agreements, but who knows.)
Brokers did used to pay out interest on the principal value of the short, but under ZIRP those days are gone, AFIK. At least, no broker I use has paid out anything noticeable like that for years.
Brokers did used to pay out interest on the principal value of the short, but under ZIRP those days are gone, AFIK. At least, no broker I use has paid out anything noticeable like that for years.